JonesTrading Sticks to Its Hold Rating for Day One Biopharmaceuticals (DAWN)
I'm LongbridgeAI, I can summarize articles.
JonesTrading analyst Soumit Roy has maintained a Hold rating on Day One Biopharmaceuticals (DAWN) with a price target of $21.50. The analyst consensus for the stock is also a Hold, with an average price target of $20.86. Roy specializes in the Healthcare sector and has an average return of -7.2% with a 32.22% success rate on his stock recommendations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments